Stromal gene signatures in large-B-cell lymphomas.

Citation data:

The New England journal of medicine, ISSN: 1533-4406, Vol: 359, Issue: 22, Page: 2313-23

Publication Year:
2008
Usage 901
Abstract Views 744
Full Text Views 74
Downloads 67
Link-outs 16
Captures 390
Readers 315
Exports-Saves 75
Mentions 3
References 2
Blog Mentions 1
Citations 894
Citation Indexes 893
Clinical Citations 1
Repository URL:
https://digitalcommons.unmc.edu/com_pathmicro_articles/32; https://ohsu.pure.elsevier.com/en/publications/e5c42faa-3bd6-4293-8953-733f52fc01fd
PMID:
19038878
DOI:
10.1056/nejmoa0802885; 10.3410/f.1148287.605435
Author(s):
Lenz, G; Wright, G; Dave, S S; Xiao, W; Powell, J; Zhao, H; Xu, W; Tan, B; Goldschmidt, N; Iqbal, J; Vose, J; Bast, M; Fu, K; Weisenburger, D D; Greiner, T C; Armitage, J O; Kyle, A; May, L; Gascoyne, R D; Connors, J M; Troen, G; Holte, H; Kvaloy, S; Dierickx, D; Verhoef, G; Delabie, J; Smeland, E B; Jares, P; Martinez, A; Lopez-Guillermo, A; Montserrat, E; Campo, E; Braziel, R M; Miller, T P; Rimsza, L M; Cook, J R; Pohlman, B; Sweetenham, J; Tubbs, R R; Fisher, R I; Hartmann, E; Rosenwald, A; Ott, G; Muller-Hermelink, H-K; Wrench, D; Lister, T A; Jaffe, E S; Wilson, W H; Chan, W C; Staudt, L M; Lymphoma/Leukemia Molecular Profiling Project Show More Hide
Publisher(s):
Faculty of 1000, Ltd.; New England Journal of Medicine (NEJM/MMS); Massachusetts Medical Society.
Tags:
Medicine; Antibodies; Monoclonal; Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Progression; Doxorubicin; Extracellular Matrix; Gene Expression; Gene Expression Profiling; Gene Expression Regulation; Neoplastic; Genes; MHC Class II; Germinal Center; Humans; Immunologic Factors; Kaplan-Meier Estimate; Lymphoma; Large B-Cell; Diffuse; Middle Aged; Multivariate Analysis; Neovascularization; Pathologic; Prednisone; Prognosis; Rituximab; Stromal Cells; Vincristine; Medicine(all); Medical Microbiology; Pathology
Most Recent Blog Mention
article description
The addition of rituximab to combination chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP), or R-CHOP, has significantly improved the survival of patients with diffuse large-B-cell lymphoma. Whether gene-expression signatures correlate with survival after treatment of diffuse large-B-cell lymphoma is unclear.